Abstract | CONTEXT: CASE REPORT: CONCLUSION:
Gemcitabine-induced pulmonary hypertension is rare and can be challenging to diagnose, as it remains a diagnosis of exclusion. However, physicians should be vigilant of new pulmonary symptoms, as delayed treatment can cause significant patient morbidity and mortality.
|
Authors | Janice Shen, Su Yun Chung, Elham Azimi-Nekoo, Jyothi Jose, Muhammad W Saif |
Journal | Pulmonary research and respiratory medicine : open journal
(Pulm Res Respir Med)
Vol. 5
Issue 1
Pg. 1-3
( 2019)
ISSN: 2377-1658 [Electronic] United States |
PMID | 32104721
(Publication Type: Journal Article)
|